{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:25:15Z","timestamp":1759778715717},"reference-count":54,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,9]]},"DOI":"10.7759\/cureus.64195","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T04:21:45Z","timestamp":1720585305000},"source":"Crossref","is-referenced-by-count":2,"title":["Challenges, Recommendations, and Epidemiology of Pulmonary Embolism in India: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Sadanand M","family":"Shetty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agam","family":"Vora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robbie","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidita","family":"M","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/lungindia.lungindia_79_21","article-title":"Prevalence and predictors of pulmonary embolism in patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"38","author":"Chaudhary N","year":"2021","unstructured":"Chaudhary N, Khan UH, Shah TH, et al.. Prevalence and predictors of pulmonary embolism in patients with acute exacerbation of chronic obstructive pulmonary disease. Lung India. 2021, 38:533-9. 10.4103\/lungindia.lungindia_79_21","journal-title":"Lung India"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1642040","article-title":"Patient assessment: Clinical presentation, imaging diagnosis, risk stratification, and the role of pulmonary embolism response team","volume":"35","author":"Friedman T","year":"2018","unstructured":"Friedman T, Winokur RS, Quencer KB, Madoff DC. Patient assessment: Clinical presentation, imaging diagnosis, risk stratification, and the role of pulmonary embolism response team. Semin Intervent Radiol. 2018, 35:116-21. 10.1055\/s-0038-1642040","journal-title":"Semin Intervent Radiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/0970-1591.45531","article-title":"Venous thromboembolism: A problem in the Indian\/Asian population?","volume":"25","author":"Agarwal S","year":"2009","unstructured":"Agarwal S, Lee AD, Raju RS, Stephen E. Venous thromboembolism: A problem in the Indian\/Asian population?. Indian J Urol. 2009, 25:11-6. 10.4103\/0970-1591.45531","journal-title":"Indian J Urol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5761\/atcs.ra.19-00158","article-title":"Current management of acute pulmonary embolism","volume":"26","author":"Martinez Licha CR","year":"2020","unstructured":"Martinez Licha CR, McCurdy CM, Maldonado SM, Lee LS. Current management of acute pulmonary embolism. Ann Thorac Cardiovasc Surg. 2020, 26:65-71. 10.5761\/atcs.ra.19-00158","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"ref5","article-title":"Management of acute pulmonary embolism: Consensus statement for Indian patients","volume":"63","author":"Dalal JJ","year":"2015","unstructured":"Dalal JJ, Amin P, Ansari AS, et al.. Management of acute pulmonary embolism: Consensus statement for Indian patients. J Assoc Physicians India. 2015, 63:41-50.","journal-title":"J Assoc Physicians India"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/2045894021992678","article-title":"Clinical profile and management of patients with acute pulmonary thromboembolism - a single centre, large observational study from India","volume":"11","author":"Muralidharan TR","year":"2021","unstructured":"Muralidharan TR, Ramesh S, Kumar BV, et al.. Clinical profile and management of patients with acute pulmonary thromboembolism - a single centre, large observational study from India. Pulm Circ. 2021, 11:2045894021992678. 10.1177\/2045894021992678","journal-title":"Pulm Circ"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.05.071","article-title":"Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: Initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry)","volume":"57","author":"Pollack CV","year":"2011","unstructured":"Pollack CV, Schreiber D, Goldhaber SZ, et al.. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: Initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J Am Coll Cardiol. 2011, 57:700-6. 10.1016\/j.jacc.2010.05.071","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07534-5","article-title":"Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)","volume":"353","author":"Goldhaber SZ","year":"1999","unstructured":"Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999, 353:1386-9. 10.1016\/S0140-6736(98)07534-5","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.726232","article-title":"Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: Findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry","volume":"117","author":"Laporte S","year":"2008","unstructured":"Laporte S, Mismetti P, D\u00e9cousus H, et al.. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: Findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation. 2008, 117:1711-6. 10.1161\/CIRCULATIONAHA.107.726232","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC)","volume":"41","author":"Konstantinides SV","year":"2020","unstructured":"Konstantinides SV, Meyer G, Becattini C, et al.. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) . Eur Heart J. 2020, 41:543-603. 10.1093\/eurheartj\/ehz405","journal-title":"Eur Heart J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2018-000327","article-title":"Fever is associated with higher morbidity and clot burden in patients with acute pulmonary embolism","volume":"5","author":"Saad M","year":"2018","unstructured":"Saad M, Shaikh DH, Mantri N, Alemam A, Zhang A, Adrish M. Fever is associated with higher morbidity and clot burden in patients with acute pulmonary embolism. BMJ Open Respir Res. 2018, 5:e000327. 10.1136\/bmjresp-2018-000327","journal-title":"BMJ Open Respir Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4070\/kcj.2017.0314","article-title":"Acute pulmonary embolism: Focus on the clinical picture","volume":"48","author":"Morrone D","year":"2018","unstructured":"Morrone D, Morrone V. Acute pulmonary embolism: Focus on the clinical picture. Korean Circ J. 2018, 48:365-81. 10.4070\/kcj.2017.0314","journal-title":"Korean Circ J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2007.03.024","article-title":"Clinical characteristics of patients with acute pulmonary embolism: Data from PIOPED II","volume":"120","author":"Stein PD","year":"2007","unstructured":"Stein PD, Beemath A, Matta F, et al.. Clinical characteristics of patients with acute pulmonary embolism: Data from PIOPED II. Am J Med. 2007, 120:871-9. 10.1016\/j.amjmed.2007.03.024","journal-title":"Am J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2013.12.037","article-title":"Study of clinical profile and management of patients with pulmonary embolism - single center study","volume":"66","author":"Calwin Davidsingh S","year":"2014","unstructured":"Calwin Davidsingh S, Srinivasan N, Balaji P, Kalaichelvan U, Mullasari AS. Study of clinical profile and management of patients with pulmonary embolism - single center study. Indian Heart J. 2014, 66:197-202. 10.1016\/j.ihj.2013.12.037","journal-title":"Indian Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/2048872612466790","article-title":"Differences in negative T waves among acute coronary syndrome, acute pulmonary embolism, and Takotsubo cardiomyopathy","volume":"1","author":"Kosuge M","year":"2012","unstructured":"Kosuge M, Ebina T, Hibi K, et al.. Differences in negative T waves among acute coronary syndrome, acute pulmonary embolism, and Takotsubo cardiomyopathy. Eur Heart J Acute Cardiovasc Care. 2012, 1:349-57. 10.1177\/2048872612466790","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.6623","article-title":"Recurrent syncope as a presentation of pulmonary embolism","volume":"12","author":"Suwanwongse K","year":"2020","unstructured":"Suwanwongse K, Shabarek N. Recurrent syncope as a presentation of pulmonary embolism. Cureus. 2020, 12:e6623. 10.7759\/cureus.6623","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1541-9215.2005.03698.x","article-title":"The diagnostic evaluation of pulmonary embolism","volume":"3","author":"McRae SJ","year":"2005","unstructured":"McRae SJ, Ginsberg JS. The diagnostic evaluation of pulmonary embolism. Am Heart Hosp J. 2005, 3:14-20. 10.1111\/j.1541-9215.2005.03698.x","journal-title":"Am Heart Hosp J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.hsr.2022.100022","article-title":"Misdiagnosis of pulmonary embolism and missed pulmonary embolism: A systematic review of the literature","volume":"3","author":"Kwok CS","year":"2022","unstructured":"Kwok CS, Wong CW, Lovatt S, Myint PK, Loke YK. Misdiagnosis of pulmonary embolism and missed pulmonary embolism: A systematic review of the literature. Health Sci Rev. 2022, 3:100022. 10.1016\/j.hsr.2022.100022","journal-title":"Health Sci Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.21037\/cdt.2017.12.01","article-title":"Imaging of acute pulmonary embolism: An update","volume":"8","author":"Moore AJ","year":"2018","unstructured":"Moore AJ, Wachsmann J, Chamarthy MR, Panjikaran L, Tanabe Y, Rajiah P. Imaging of acute pulmonary embolism: An update. Cardiovasc Diagn Ther. 2018, 8:225-43. 10.21037\/cdt.2017.12.01","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1311792","article-title":"Imaging tests in the diagnosis of pulmonary embolism","volume":"33","author":"Mos IC","year":"2012","unstructured":"Mos IC, Klok FA, Kroft LJ, de Roos A, Huisman MV. Imaging tests in the diagnosis of pulmonary embolism. Semin Respir Crit Care Med. 2012, 33:138-43. 10.1055\/s-0032-1311792","journal-title":"Semin Respir Crit Care Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00250112","article-title":"Pulmonary embolism in patients with CKD and ESRD","volume":"7","author":"Kumar G","year":"2012","unstructured":"Kumar G, Sakhuja A, Taneja A, Majumdar T, Patel J, Whittle J, Nanchal R. Pulmonary embolism in patients with CKD and ESRD. Clin J Am Soc Nephrol. 2012, 7:1584-90. 10.2215\/CJN.00250112","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.21037\/cdt.2016.11.05","article-title":"Multidisciplinary pulmonary embolism response teams and systems","volume":"6","author":"Monteleone PP","year":"2016","unstructured":"Monteleone PP, Rosenfield K, Rosovsky RP. Multidisciplinary pulmonary embolism response teams and systems. Cardiovasc Diagn Ther. 2016, 6:662-7. 10.21037\/cdt.2016.11.05","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S151196","article-title":"Multidisciplinary approach to the management of pulmonary embolism patients: The pulmonary embolism response team (PERT)","volume":"11","author":"Root CW","year":"2018","unstructured":"Root CW, Dudzinski DM, Zakhary B, Friedman OA, Sista AK, Horowitz JM. Multidisciplinary approach to the management of pulmonary embolism patients: The pulmonary embolism response team (PERT). J Multidiscip Healthc. 2018, 11:187-95. 10.2147\/JMDH.S151196","journal-title":"J Multidiscip Healthc"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4103\/0972-5229.178178","article-title":"Arrive: A retrospective registry of Indian patients with venous thromboembolism","volume":"20","author":"Kamerkar DR","year":"2016","unstructured":"Kamerkar DR, John MJ, Desai SC, Dsilva LC, Joglekar SJ. Arrive: A retrospective registry of Indian patients with venous thromboembolism. Indian J Crit Care Med. 2016, 20:150-8. 10.4103\/0972-5229.178178","journal-title":"Indian J Crit Care Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97638-0","article-title":"Development and validation of a novel risk assessment model to estimate the probability of pulmonary embolism in postoperative patients","volume":"11","author":"Wang MF","year":"2021","unstructured":"Wang MF, Li FX, Feng LF, et al.. Development and validation of a novel risk assessment model to estimate the probability of pulmonary embolism in postoperative patients. Sci Rep. 2021, 11:18087. 10.1038\/s41598-021-97638-0","journal-title":"Sci Rep"},{"key":"ref26","article-title":"Pulmonary embolism, part II: Management","volume":"18","author":"B\u0115lohl\u00e1vek J","year":"2013","unstructured":"B\u0115lohl\u00e1vek J, Dytrych V, Linhart A. Pulmonary embolism, part II: Management. Exp Clin Cardiol. 2013, 18:139-47.","journal-title":"Exp Clin Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2020.06.002","article-title":"Reperfusion therapies in pulmonary embolism-state of the art and expert opinion: A position paper from the \"Unit\u00e9 de Soins Intensifs de Cardiologie\" group of the French Society of Cardiology","volume":"113","author":"Delmas C","year":"2020","unstructured":"Delmas C, Aissaoui N, Meneveau N, et al.. Reperfusion therapies in pulmonary embolism-state of the art and expert opinion: A position paper from the \"Unit\u00e9 de Soins Intensifs de Cardiologie\" group of the French Society of Cardiology. Arch Cardiovasc Dis. 2020, 113:749-59. 10.1016\/j.acvd.2020.06.002","journal-title":"Arch Cardiovasc Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli G","year":"2013","unstructured":"Agnelli G, Buller HR, Cohen A, et al.. Apixaban for extended treatment of venous thromboembolism. N Engl J Med. 2013, 368:699-708. 10.1056\/NEJMoa1207541","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli G","year":"2013","unstructured":"Agnelli G, Buller HR, Cohen A, et al.. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013, 369:799-808. 10.1056\/NEJMoa1302507","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2015.04.020","article-title":"A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: The SEATTLE II study","volume":"8","author":"Piazza G","year":"2015","unstructured":"Piazza G, Hohlfelder B, Jaff MR, et al.. A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: The SEATTLE II study. JACC Cardiovasc Interv. 2015, 8:1382-92. 10.1016\/j.jcin.2015.04.020","journal-title":"JACC Cardiovasc Interv"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1110","article-title":"The Penumbra System: A mechanical device for the treatment of acute stroke due to thromboembolism","volume":"29","author":"Bose A","year":"2008","unstructured":"Bose A, Henkes H, Alfke K, et al.. The Penumbra System: A mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol. 2008, 29:1409-13. 10.3174\/ajnr.A1110","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsha.2015.05.003","article-title":"Novel oral anticoagulants and the 73rd anniversary of historical warfarin","volume":"28","author":"Shehab A","year":"2016","unstructured":"Shehab A, Elnour AA, Bhagavathula AS, et al.. Novel oral anticoagulants and the 73rd anniversary of historical warfarin. J Saudi Heart Assoc. 2016, 28:31-45. 10.1016\/j.jsha.2015.05.003","journal-title":"J Saudi Heart Assoc"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/s13584-019-0285-9","article-title":"Clinical pharmacist led hospital-wide direct oral anticoagulant stewardship program","volume":"8","author":"Perlman A","year":"2019","unstructured":"Perlman A, Horwitz E, Hirsh-Raccah B, et al.. Clinical pharmacist led hospital-wide direct oral anticoagulant stewardship program. Isr J Health Policy Res. 2019, 8:19. 10.1186\/s13584-019-0285-9","journal-title":"Isr J Health Policy Res"},{"key":"ref34","article-title":"Direct oral anticoagulants: A user's guide","volume":"57","author":"Suvash Shrestha","year":"2017","unstructured":"Suvash Shrestha, On Chen, Robert Frankel, Yisachar Greenberg, Felix Yang. Direct oral anticoagulants: A user's guide. Consult 360. 2017, 57:","journal-title":"Consult 360"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman S","year":"2009","unstructured":"Schulman S, Kearon C, Kakkar AK, et al.. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med. 2009, 361:2342-52. 10.1056\/NEJMoa0906598","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"The EINSTEIN-PE Investigators","year":"2012","unstructured":"The EINSTEIN-PE Investigators. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012, 366:1287-97. 10.1056\/NEJMoa1113572","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"The Hokusai-VTE Investigators","year":"2013","unstructured":"The Hokusai-VTE Investigators. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med. 2013, 369:1406-15. 10.1056\/NEJMoa1306638","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger CB","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, et al.. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011, 365:981-92. 10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1668523","article-title":"Apixaban versus dalteparin for the treatment of acute venous thromboembolism in patients with cancer: The Caravaggio study","volume":"118","author":"Agnelli G","year":"2018","unstructured":"Agnelli G, Becattini C, Bauersachs R, et al.. Apixaban versus dalteparin for the treatment of acute venous thromboembolism in patients with cancer: The Caravaggio study. Thromb Haemost. 2018, 118:1668-78. 10.1055\/s-0038-1668523","journal-title":"Thromb Haemost"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1642622","article-title":"Novel anticoagulant treatment for pulmonary embolism with direct oral anticoagulants phase 3 trials and clinical practice","volume":"35","author":"Tromeur C","year":"2018","unstructured":"Tromeur C, van der Pol LM, Mairuhu AT, Leroyer C, Couturaud F, Huisman MV, Klok FA. Novel anticoagulant treatment for pulmonary embolism with direct oral anticoagulants phase 3 trials and clinical practice. Semin Intervent Radiol. 2018, 35:83-91. 10.1055\/s-0038-1642622","journal-title":"Semin Intervent Radiol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024425","article-title":"Extended anticoagulation after pulmonary embolism: A multicenter observational cohort analysis","volume":"11","author":"Chopard R","year":"2022","unstructured":"Chopard R, Albertsen IE, Ecarnot F, et al.. Extended anticoagulation after pulmonary embolism: A multicenter observational cohort analysis. J Am Heart Assoc. 2022, 11:e024425. 10.1161\/JAHA.121.024425","journal-title":"J Am Heart Assoc"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.2147\/OAEM.S103912","article-title":"Pulmonary embolism: New treatments for an old problem","volume":"8","author":"Ryan J","year":"2016","unstructured":"Ryan J. Pulmonary embolism: New treatments for an old problem. Open Access Emerg Med. 2016, 8:87-95. 10.2147\/OAEM.S103912","journal-title":"Open Access Emerg Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz367","article-title":"Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: An international multicentre single-arm clinical trial","volume":"41","author":"Barco S","year":"2020","unstructured":"Barco S, Schmidtmann I, Ageno W, et al.. Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: An international multicentre single-arm clinical trial. Eur Heart J. 2020, 41:509-18. 10.1093\/eurheartj\/ehz367","journal-title":"Eur Heart J"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144856","article-title":"Comparison of the novel oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in the initial and long-term treatment and prevention of venous thromboembolism: Systematic review and network meta-analysis","volume":"10","author":"Cohen AT","year":"2015","unstructured":"Cohen AT, Hamilton M, Mitchell SA, et al.. Comparison of the novel oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in the initial and long-term treatment and prevention of venous thromboembolism: Systematic review and network meta-analysis. PLoS One. 2015, 10:e0144856. 10.1371\/journal.pone.0144856","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007%2Fs11739-021-02765-1","article-title":"Unprovoked or provoked venous thromboembolism: Not the prevalent criterion to decide on anticoagulation extension in clinical practice of various countries\u2014the prospective, international, observational WHITE study","volume":"17","author":"Palareti G","year":"20221","unstructured":"Palareti G, Bignamini A, Cini M, et al.. Unprovoked or provoked venous thromboembolism: Not the prevalent criterion to decide on anticoagulation extension in clinical practice of various countries\u2014the prospective, international, observational WHITE study. Intern Emerg Med. 20221, 17:71-82. 10.1007%2Fs11739-021-02765-1","journal-title":"Intern Emerg Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.025471","article-title":"Length of anticoagulation in provoked venous thromboembolism: A multicenter study of how real-world practice mirrors guideline recommendations","volume":"11","author":"Joyce E","year":"2022","unstructured":"Joyce E, Haymart B, Kong X, et al.. Length of anticoagulation in provoked venous thromboembolism: A multicenter study of how real-world practice mirrors guideline recommendations. J Am Heart Assoc. 2022, 11:e025471. 10.1161\/JAHA.122.025471","journal-title":"J Am Heart Assoc"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-020-02340-0","article-title":"Management of acute pulmonary embolism 2019: What is new in the updated European guidelines?","volume":"15","author":"Konstantinides S","year":"2020","unstructured":"Konstantinides S, Meyer G. Management of acute pulmonary embolism 2019: What is new in the updated European guidelines?. Intern Emerg Med. 2020, 15:957-66. 10.1007\/s11739-020-02340-0","journal-title":"Intern Emerg Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915103","article-title":"Apixaban for the treatment of venous thromboembolism associated with cancer","volume":"382","author":"Agnelli G","year":"2020","unstructured":"Agnelli G, Becattini C, Meyer G, et al.. Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med. 2020, 382:1599-607. 10.1056\/NEJMoa1915103","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1720975","article-title":"Bleeding with apixaban and dalteparin in patients with cancer-associated venous thromboembolism: Results from the Caravaggio study","volume":"121","author":"Ageno W","year":"2021","unstructured":"Ageno W, Vedovati MC, Cohen A, et al.. Bleeding with apixaban and dalteparin in patients with cancer-associated venous thromboembolism: Results from the Caravaggio study. Thromb Haemost. 2021, 121:616-24. 10.1055\/s-0040-1720975","journal-title":"Thromb Haemost"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.8034","article-title":"Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: Results of a randomized trial (SELECT-D)","volume":"36","author":"Young AM","year":"2018","unstructured":"Young AM, Marshall A, Thirlwall J, et al.. Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: Results of a randomized trial (SELECT-D). J Clin Oncol. 2018, 36:2017-23. 10.1200\/JCO.2018.78.8034","journal-title":"J Clin Oncol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"Raskob GE","year":"2018","unstructured":"Raskob GE, van Es N, Verhamme P, et al.. Edoxaban for the treatment of cancer-associated venous thromboembolism. N Engl J Med. 2018, 378:615-24. 10.1056\/NEJMoa1711948","journal-title":"N Engl J Med"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.12020","article-title":"The comparative effectiveness of direct oral anti-coagulants and low molecular weight heparins for prevention of recurrent venous thromboembolism in cancer: The CANVAS pragmatic randomized trial","volume":"39","author":"Schrag D","year":"2021","unstructured":"Schrag D, Uno H, Rosovsky RP, et al.. The comparative effectiveness of direct oral anti-coagulants and low molecular weight heparins for prevention of recurrent venous thromboembolism in cancer: The CANVAS pragmatic randomized trial. J Clin Oncol. 2021, 39:12020-12020. 10.1200\/JCO.2021.39.15_suppl.12020","journal-title":"J Clin Oncol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13596","article-title":"Update on guidelines for the management of cancer-associated thrombosis","volume":"26","author":"Streiff MB","year":"2021","unstructured":"Streiff MB, Abutalib SA, Farge D, Murphy M, Connors JM, Piazza G. Update on guidelines for the management of cancer-associated thrombosis. Oncologist. 2021, 26:e24-40. 10.1002\/onco.13596","journal-title":"Oncologist"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2010.02204.x","article-title":"Comparison of the Wells and Revised Geneva Scores for the diagnosis of pulmonary embolism: An Australian experience","volume":"41","author":"Wong DD","year":"2011","unstructured":"Wong DD, Ramaseshan G, Mendelson RM. Comparison of the Wells and Revised Geneva Scores for the diagnosis of pulmonary embolism: An Australian experience. Intern Med J. 2011, 41:258-63. 10.1111\/j.1445-5994.2010.02204.x","journal-title":"Intern Med J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/211686-challenges-recommendations-and-epidemiology-of-pulmonary-embolism-in-india-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T04:21:51Z","timestamp":1720585311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/211686-challenges-recommendations-and-epidemiology-of-pulmonary-embolism-in-india-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":54,"URL":"https:\/\/doi.org\/10.7759\/cureus.64195","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,9]]}}}